Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma

por Gardner, Heather L., Rippy, Sarah B., Bear, Misty D., Cronin, Kim L., Heeb, Heather, Burr, Holly, Cannon, Claire M., Penmetsa, Kumar V., Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A.
Publicado 2018

A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma

por Rippy, Sarah B., Gardner, Heather L., Nguyen, Sandra M., Warry, Emma E., Portela, Roberta A., Drost, William Tod, Hostnik, Eric T., Green, Eric M., Chew, Dennis J., Peng, Juan, London, Cheryl A.
Publicado 2016

Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma

por Rippy, Sarah B., Gardner, Heather L., Nguyen, Sandra M., Warry, Emma E., Portela, Roberta F., Drost, William Tod, Hostnik, Eric T., Green, Eric M., Chew, Dennis J., Peng, Juan, London, Cheryl A.
Publicado 2016